![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2019
Brown, Jennifer R.; Moslehi, Javid; Ewer, Michael S.; O'Brien, Susan M.; Ghia, Paolo; Cymbalista, Florence; Shanafelt, Tait D.; Fraser, Graeme; Rule, Simon; Coutre, Steven E.; Dilhuydy, Marie-Sarah; Cramer, Paula; Jaeger, Ulrich; Dreyling, Martin; Byrd, John C.; Treon, Steven; Liu, Emily Y.; Chang, Stephen; Bista, Amulya; Vempati, Rama; Boornazian, Lisa; Valentino, Rudolph; Reddy, Vijay; Mahler, Michelle; Yang, Huiying; Graef, Thorsten und Burger, Jan A.
(2019):
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.
In: British Journal of Haematology, Bd. 184, Nr. 4: S. 558-569
Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Duerig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco und Hopfinger, Georg
(2019):
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.
In: Leukemia & Lymphoma, Bd. 60, Nr. 3: S. 649-657
2018
Cramer, Paula; Tresckow, Julia von; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara und Hallek, Michael
(2018):
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial.
In: Lancet Oncology, Bd. 19, Nr. 9: S. 1215-1228
2017
Brown, Jennifer R.; Moslehi, Javid; O'Brien, Susan; Ghia, Paolo; Hillmen, Peter; Cymbalista, Florence; Shanafelt, Tait D.; Fraser, Graeme; Rule, Simon; Kipps, Thomas J.; Coutre, Steven; Dilhuydy, Marie-Sarah; Cramer, Paula; Tedeschi, Alessandra; Jäger, Ulrich; Dreyling, Martin; Byrd, John C.; Howes, Angela; Todd, Michael; Vermeulen, Jessica; James, Danelle F.; Clow, Fong; Styles, Lori; Valentino, Rudy; Wildgust, Mark; Mahler, Michelle und Burger, Jan A.
(2017):
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.
In: Haematologica, Bd. 102, Nr. 10: S. 1796-1805
2016
Maurer, Christian; Pflug, Natali; Bahlo, Jasmin; Kluth, Sandra; Rhein, Christina; Cramer, Paula; Gross-Ophoff, Carolin; Langerbeins, Petra; Fink, Anna-Maria; Eichhorst, Barbara; Kreuzer, Karl-Anton; Fischer, Norbert; Tausch, Eugen; Stilgenbauer, Stephan; Böttcher, Sebastian; Döhner, Hartmut; Kneba, Michael; Dreyling, Martin; Binder, Mascha; Hallek, Michael; Wendtner, Clemens-Martin; Bergmann, Manuela und Fischer, Kirsten
(2016):
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia.
In: European Journal of Haematology, Bd. 97, Nr. 3: S. 253-260